Current guidelines recommend up to 5 years of follow-up assessment for patients with localized renal cell carcinoma treated by nephrectomy; however, the recommendations are supported only by low-level evidence, and a recent study suggests considerably prolonged follow up is needed. Thus, approaches to follow-up imaging assessments and their actual benefit on disease outcome require further clarification.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
11 February 2015
In the version of this article published online, the following sentence had an error: 'NCCN and AUA guidelines recommend maximum durations for follow-up imaging assessments of 3 years for low-risk disease and 5 years for moderate-to-high-risk disease'. This error has been corrected for the HTML and PDF versions of the article published online and in print.
References
American Urological Association. Follow-up for clinically localized renal neoplasms: AUA Guidelines 2013 [online], (2013).
Stewart, S. B. et al. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. J. Clin. Oncol. 32, 4059–4065 (2014).
Schaner, E. G. et al. Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: a prospective radiologic–pathologic study. AJR Am. J. Roentgenol. 131, 51–54 (1978).
Tollefson, M. K., Takahashi, N. & Leibovich, B. C. Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma. Curr. Urol. Rep. 8, 38–43 (2007).
Paparel, P. et al. Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. A multi-institutional study. J. Surg. Oncol. 109, 126–131 (2014).
Johnson, A. et al. Feasibility and outcomes of repeat partial nephrectomy. J. Urol. 180, 89–93 (2008).
Georgiades, C. S. & Rodriguez, R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc. Intervent. Radiol. 37, 1494–1499 (2014).
Escudier, B. et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 25 (Suppl. 3), iii49–iii56 (2014).
Thibault, C. et al. Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours. Eur. J. Cancer 50, 1284–1290 (2014).
Basu, S., Biyani, C. S., Sundaram, S. K. & Spencer, J. A survey of follow-up practice of urologists across Britain and Ireland following nephrectomy for renal cell carcinoma. Clin. Radiol. 61, 854–860 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Patard, JJ., Escudier, B. Towards rational post-nephrectomy follow-up guidelines in RCC. Nat Rev Clin Oncol 12, 131–132 (2015). https://doi.org/10.1038/nrclinonc.2015.17
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2015.17
